Welcome to the Highlights from TCT resource page, your central portal for information presented at the Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium. Bookmark this page and visit it often to read results from important clinical trials in interventional cardiology, watch video perspectives from key opinion leaders and learn about novel treatment options.
Meeting News Coverage
October 15, 2015
SAN FRANCISCO — One-year follow-up data from the TOTAL trial presented at the annual TCT Scientific Symposium showed routine thrombus…
Meeting News CoveragePerspective
October 15, 2015
SAN FRANCISCO — A polymer-free biolimus-coated stent demonstrated better safety and efficacy than a bare-metal stent when used with a 1-month…
Meeting News Coverage
October 15, 2015
SAN FRANCISCO — Treatment with ranolazine did not lower rates of ischemia-driven revascularization or hospitalization without revascularization…
Meeting News Coverage
October 14, 2015
SAN FRANCISCO — In patients with STEMI presenting for care late after the onset of symptoms, routine thrombus aspiration before PCI did not…
Meeting News Coverage
October 14, 2015
SAN FRANCISCO — In a session focused on lower-extremity intervention in superficial femoral artery and popliteal disease, one presenter…
Meeting News Coverage
October 14, 2015
SAN FRANCISCO — In a multicenter trial to enable approval of the Absorb bioresorbable vascular scaffold in China, the device was noninferior to…
Meeting News Coverage
October 13, 2015
SAN FRANCISCO — Using CT to estimate fractional flow reserve in evaluating patients who are stable but show signs of CAD could improve resource…
Meeting News Coverage
October 13, 2015
SAN FRANCISCO — A novel drug-coated stent that is both polymer- and carrier-free was noninferior vs. first-generation paclitaxel-eluting stents…
Meeting News Coverage
October 13, 2015
SAN FRANCISCO — The LIBERTY-360 and ENDOMAX trials have the potential to provide novel, much-needed data on the use of available endovascular…
Meeting News CoveragePerspective
October 12, 2015
SAN FRANCISCO — An everolimus-eluting bioresorbable vascular scaffold was noninferior to a cobalt-chromium everolimus-eluting stent for target…